Androgen deprivation therapy is a lifesaving therapy used by thousands of men each year, but some patients are warning of ...

Explore the Global Prostate Care Market's growth, projected to reach USD 69.91 billion by 2031, driven by demographic shifts, tech advances, and the rising incidence of prostate conditions. Key ...

In Malaysia, prostate cancer has been the third-most common type of cancer among men since 2012, doctors caution.

Novartis shares climb on strong Cosentyx sales, franchise growth, and a new malaria drug approval despite political risks.

Unlike traditional chemotherapy which affects the entire body, theranostics focuses only on the cancer. This precision often ...

NJBIZ spotlights under-recognized health care leaders, from startup founders to behind-the-scenes pros driving innovation.

New research published in the July 2025 issue of JNCCN—Journal of the National Comprehensive Cancer Network offers encouraging news for men diagnosed with nonmetastatic prostate cancer.